Knee injections for arthritis? Save your money, study says

By Kathleen Doheny, HealthDay Reporter
Knee injections for arthritis? save your money, study says
Hyaluronic acid has little effect on pain, none on function, new review states.

(HealthDay) -- It's not good news for baby boomers with arthritic knees: Injections of hyaluronic acid have little effect on pain and no effect on function, according to a new analysis.

Worse, the injections may cause serious harm, Swiss researchers found.

-- a lubricant in joint fluid that acts as a -- declines with the wear-and-tear type of arthritis known as osteoarthritis. When nonsteroidal anti-inflammatory drugs don't provide relief, doctors sometimes prescribe injections of hyaluronic acid, also called viscosupplementation.

"Unfortunately, there is no evidence to suggest that viscosupplementation results in any relevant reduction in symptoms in patients with ," said study co-author Dr. Peter Juni, professor of at the University of Bern in Switzerland.

Moreover, his research suggested the injections could cause gastrointestinal and and other harmful side effects. As a result, Juni said he sees no role for the therapy.

"There is a concerning increase in adverse events, which should prevent patients and physicians from using this approach," he said.

The analysis is scheduled to be published online June 12 in the journal .

The U.S. in 1997 approved the injections, which are commercially available from several companies and much more costly than . In 2006, injections for a six-month period ranged from $850 to $1,840, according to a pharmaceutical report.

For the study, Juni's team reviewed 89 studies that compared injections with either a or no treatment. In all, the studies involved more than 12,000 adults aged 50 to 72.

The effect on pain was minimal, and the injections had no effect on functioning, the researchers found.

In some of the studies, the injections reached peak effectiveness at eight weeks, then declined.

Looking at safety, the researchers detected a 40 percent increased risk for serious side effects, such as gastrointestinal problems, with the injections. Flare-ups -- typically a hot, swollen knee 24 to 72 hours after injection -- were noted, but not in statistically significant numbers. Less strong evidence suggested associations -- but not cause-and-effect relationships -- with cardiovascular events and cancer.

Despite these findings, a surgeon not involved in the study said he still sees a possible role for the injections in certain patients.

"Viscosupplementation therapy for the knee appears to have some transient improvement in a relatively small number of patients for variable periods of time -- most often less than six to 12 months," said Dr. William Robb, III, chairman of orthopedic surgery at North Shore University Health System in Evanston, Ill. "In some patients -- particularly patients who have received previous viscosupplements -- acute adverse reactions have been seen and may persist for several weeks, occasionally months."

However, "in none of these cases did the adverse reaction require surgical treatment," he added.

Robb said he looks at the pros and cons from a patient's perspective. Many turn to the injections to avoid surgery or medications, which can have their own harmful side effects, he said.

"Some patients, however -- particularly patients with earlier stage arthritis -- benefitted from viscosupplementation for periods of time sufficient to continue the use of this therapy," he said.

Further research would help determine which patients benefit so doctors could tailor the therapy effectively, he said.

The authors pointed out several study limitations, saying the methodology of some of the studies was flawed and the overall quality generally low. Also, many provided no information on safety.

More information: To learn more about viscosupplementation, visit the American Academy of Orthopaedic Surgeons.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Prompt diagnosis of psoriatic arthritis crucial

Oct 24, 2014

Research led by Conway Fellow, Professor Oliver FitzGerald in St Vincent's University Hospital shows that a delay of more than 6 months from initial symptoms to a diagnosis of psoriatic arthritis leads to poorer outcomes ...

Mummy remains refute antiquity of ankylosing spondylitis

Oct 20, 2014

Ankylosing spondylitis is a systemic disease that causes inflammation in the spinal joints and was thought to have affected members of the ancient Egyptian royal families. Now a new study published in Arthritis & Rheumatology, a jour ...

Arthritis sufferers excluded from everyday life

Oct 13, 2014

Arthritis is the second leading cause of disability in Australia with many sufferers so severely disabled they cannot engage in basic everyday activities, new UNSW research has found.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.